Precision Medicine Market : Global Opportunities & Forecast (2018-2025)-GMI Research

Global Precision Medicine Market by Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Drug Discovery, Bioinformatics), by Application (Oncology, Neurology, Immunology, Respiratory, Hematology, Others) and by Geography - Opportunities & Forecast 2018-2025

Precision medicine market is gaining momentum over past few years, with trend likely to continue due to novel approach of treatment it offers. Precision medicine deals with preventive health and disease treatment approach based on individual’s genetic profile and lifestyle. The approach offers accurate treatment and disease prevention strategies as against standard therapies that may not be effective for entire population.

Download Sample Brochure : https://www.gmiresearch.com/sample-research-report.php?rid=119

Precision medicine is being eyed upon as lucrative business investment opportunity by the major pharmaceutical companies owing to the rising patient preference for personalized treatment, advancements in wireless technologies and big data analytics, and tremendous increase in genetic diseases such as cancer. Moreover, there has been a remarkable increase in the research areas pertaining to precision medicine over past few years suggesting a positive growth in the future. 

Favourable government initiatives are likely to positively influence the precision medicine market growth. For instance, the UK government has devoted USD 212.8 million for developing technologically advanced infrastructure to manufacture innovative medicine such as precision medicine through its Industrial Strategy Challenge Fund initiated in December 2017. While in U.S., in 2015, President Obama launched the Precision Medicine Initiative to encourage research in the field.   

Various notable players operating in the precision medicine market include Illumina, Inc., GE Healthcare, Roche Group, bioMerieux SA, IBM Corporation, Novartis AG, and Abbott Laboratories among others.

The global precision medicine market is categorized into technology, application, and key geographies segments. On the basis of technology, the market has been segmented into Gene Sequencing, Big Data Analytics, Companion Diagnostics, Bioinformatics, and Drug Discovery. On the basis of application, the market is segmented into Oncology, Neurology, Immunology, Respiratory, Hematology, and Others.

This research report on precision medicine market provides in-depth analysis of the global precision medicine market based on technology, application, and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for precision medicine market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent development in the market.

Key questions answered in this research report:
1-    At what pace is precision medicine market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the precision medicine market?
4-    What are the various application areas and how they are poised to grow?

The global precision medicine market is segmented on the basis of technology, application, and geography:

Global Precision Medicine Market by Technology

·         Big Data Analytics

·         Gene Sequencing

·         Companion Diagnostics

·         Drug Discovery

·         Bioinformatics

Global Precision Medicine Market by Application

·         Oncology

·         Neurology

·         Immunology

·         Respiratory

·         Hematology

·         Others 

Global Precision Medicine Market by Geography

·         North America

·         Asia-Pacific

·         Europe

·         Rest of World 

Global Precision Medicine Market Competitive Landscape 

·         Major Players and their Key Strategies 

·         New product launches

·         Mergers and acquisitions

·        Collaborations, partnerships, agreements and joint venture

BUY Premuim Report : https://www.gmiresearch.com/buy-research-report.php?rid=119&licence=singaluser

Table of Contents

1    Executive Summary 

2    Introduction    
2.1    Study Objectives
2.2    Market Definition
2.2.1    Market Covered
2.2.2.    Geographical Coverage
2.2.3.    Study Years & Currency
2.3.    Market Stakeholders
2.4.    Key Questions this Study will Answer
2.5.    GMI Research’s Approach & Methodology

3    Global Precision Medicine Market - Overview     
3.1    Introduction         `
3.2    Market Segmentation
3.3    Value Chain Analysis
3.5    Drivers
3.6    Restraints
3.7    Trends

4    Global Precision Medicine Market Revenue Forecast till 2025

5    Global Precision Medicine Market by Technology Revenue Forecast till 2025
5.1.    Big Data Analytics
5.2.    Gene Sequencing
5.3.    Companion Diagnostics
5.4.    Drug Discovery
5.5.    Bioinformatics

6    Global Precision Medicine Market by Application Revenue Forecast till 2025 
6.1.    Oncology
6.2.    Neurology
6.3.    Immunology
6.4.    Respiratory
6.5.    Hematology
6.6.    Others

7    Global Precision Medicine Market by Geography Revenue Forecast till 2025 
7.1.    North America Precision Medicine Market Revenue Forecast till 2025
7.1.1.    North America Precision Medicine Market by Type (Option 1: 25% customization)
7.1.1.1.    Big Data Analytics
7.1.1.2.    Gene Sequencing
7.1.1.3.    Companion Diagnostics
7.1.1.4.    Drug Discovery
7.1.1.5.    Bioinformatics
7.1.2.    North America Precision Medicine Market by Application
7.1.2.1.    Oncology
7.1.2.2.    Neurology
7.1.2.3.    Immunology
7.1.2.4.    Respiratory
7.1.2.5.    Hematology
7.1.2.6.    Others
7.2    Europe Precision Medicine Market Revenue Forecast till 2025
7.2.1.    Europe Precision Medicine Market by Type (Option 2: 25% customization)
7.2.1.1.    Big Data Analytics
7.2.1.2.    Gene Sequencing
7.2.1.3.    Companion Diagnostics
7.2.1.4.    Drug Discovery
7.2.1.5.    Bioinformatics
7.2.2.    Europe Precision Medicine Market by Application
7.2.2.1.    Oncology
7.2.2.2.    Neurology
7.2.2.3.    Immunology
7.2.2.4.    Respiratory
7.2.2.5.    Hematology
7.2.2.6.    Others
7.3    Asia-Pacific Precision Medicine Market Revenue Forecast till 2025
7.3.1.    Asia-Pacific Precision Medicine Market by Type (Option 3: 25% customization)
7.3.1.1.    Big Data Analytics
7.3.1.2.    Gene Sequencing
7.3.1.3.    Companion Diagnostics
7.3.1.4.    Drug Discovery
7.3.1.5.    Bioinformatics
7.3.2.    Asia-Pacific Precision Medicine Market by Application
7.3.2.1.    Oncology
7.3.2.2.    Neurology
7.3.2.3.    Immunology
7.3.2.4.    Respiratory
7.3.2.5.    Hematology
7.3.2.6.    Others
7.4    Rest of the World Precision Medicine Market Revenue Forecast till 2025
7.4.1.    Rest of the World Precision Medicine Market by Type (Option 4: 25% customization)
7.4.1.1.    Big Data Analytics
7.4.1.2.    Gene Sequencing
7.4.1.3.    Companion Diagnostics
7.4.1.4.    Drug Discovery
7.4.1.5.    Bioinformatics
7.4.2.    Rest of the World Precision Medicine Market by Application
7.4.2.1.    Oncology
7.4.2.2.    Neurology
7.4.2.3.    Immunology
7.4.2.4.    Respiratory
7.4.2.5.    Hematology
7.4.2.6.    Others

8    Competitive Landscape 
8.1.    Industry Attractiveness
8.1.1.    Porter's Five Forces Analysis
8.2.    Major Players and Key Strategies

9    Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)   
9.1.    Abbott Laboratories
9.1.1.    Company Overview
9.1.2.    Financials
9.1.3.    Recent Developments
9.2    bioMerieux SA
9.2.1.    Company Overview
9.2.2.    Financials
9.2.3.    Recent Developments
9.3    Illumina, Inc.
9.3.1.    Company Overview
9.3.2.    Financials
9.3.3.    Recent Developments
9.4    GE Healthcare
9.4.1.    Company Overview
9.4.2.    Financials
9.4.3.    Recent Developments
9.5.    Roche Group
9.5.1.    Company Overview
9.5.2.    Financials
9.5.3.    Recent Developments
9.6.    Nanostring Technologies
9.6.1.    Company Overview
9.6.2.    Financials
9.6.3.    Recent Developments
9.7.    IBM Corporation
9.7.1.    Company Overview
9.7.2.    Financials
9.7.3.    Recent Developments
9.8.    Thermo Fisher Scientific
9.8.1.    Company Overview
9.8.2.    Financials
9.8.3.    Recent Developments
9.9.    Novartis AG
9.9.1.    Company Overview
9.9.2.    Financials
9.9.3.    Recent Developments
9.10.    QIAGEN N.V
9.10.1.    Company Overview
9.10.2.    Financials
9.10.3.    Recent Developments

For more details, browse the Table of Contents:  https://www.gmiresearch.com/report/gobal-precision-medicine-market-2018-2025-by-technology-application-geography-opportunities-forecast-share-trends-compony-profile.html

Read More..

The Views and Opinions expressed in this article are the author's own and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors.

Relmada Therapeutics (Nasdaq: RLMD) Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression

**Disclaimer: Crown Equity Holdings Inc. has received $5,000.00 (five thousand dollars) in cash from Nass Valley Gateway Ltd. (CSE:NVG) (FSE:3NVN) for 30 days of advertisement services